For the readers interested in the stock health of CureVac N.V. (CVAC). It is currently valued at $98.06. When the transactions were called off in the previous session, Stock hit the highs of $107.315, after setting-off with the price of $104.00. Company’s stock value dipped to $103.01 during the trading on the day. When the trading was stopped its value was $105.80.
Recently in News on June 2, 2021, CureVac Appoints Klaus Edvardsen as Chief Development Officer. CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced the appointment of Klaus Edvardsen, MD, PhD, as Chief Development Officer. The appointment of Dr. Edvardsen will take effect on August 1, 2021. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, CureVac N.V. shares are logging -35.40% during the 52-week period from high price, and 171.26% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $36.15 and $151.80.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 691145 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the CureVac N.V. (CVAC) recorded performance in the market was 30.50%, having the revenues showcasing 22.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 19.46B, as it employees total of 500 workers.
The Analysts eye on CureVac N.V. (CVAC)
During the last month, 2 analysts gave the CureVac N.V. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 102.27, with a change in the price was noted -4.99. In a similar fashion, CureVac N.V. posted a movement of -4.83% for the period of last 100 days, recording 997,214 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CVAC is recording 0.08 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.07.
Technical rundown of CureVac N.V. (CVAC)
Raw Stochastic average of CureVac N.V. in the period of last 50 days is set at 26.45%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.95%. In the last 20 days, the company’s Stochastic %K was 26.21% and its Stochastic %D was recorded 43.05%.
Considering, the past performance of CureVac N.V., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 30.50%. The shares increased approximately by -7.57% in the 7-day charts and went down by 7.99% in the period of the last 30 days. Common stock shares were driven by 22.17% during last recorded quarter.